Myocardial function and lipid metabolism in the chronic alcoholic animal.
In view of the variables that obscure the pathogenesis of cardiomyopathy, a study was undertaken in mongrel dogs fed ethanol as 36% of calories for up to 22 mo. Both the experimental and control groups maintained body weight, hematocrit, plasma vitamin, and protein levels. Left ventricular function was evaluated in the intact anesthetized dog using indicator dilution for end-diastolic and stroke volume determinations. During increased afterload with angiotensin, the ethanol group exhibited a larger rise of end-diastolic pressure (P<0.01), whereas end-diastolic and stroke volume responses were significantly less than in controls. Preload increments with saline elicited a significantly higher end-diastolic pressure rise in the ethanol group (P<0.01). No hypertrophy, inflammation, or fibrosis was present and it was postulated that the enhanced diastolic stiffness was related to accumulation of Alcian Blue-positive material in the ventricular interstitium. To evaluate myocardial lipid metabolism, [1-(14)C]oleic acid was infused systemically. Plasma specific activity and myocardial lipid uptake were similar in both groups. There was a significantly increased incorporation of label into triglyceride, associated with a reduced (14)CO(2) production, considered the basis for a twofold increment of triglyceride content. In addition, diminished incorporation of [(14)C]oleic acid into phospholipid was observed accompanied by morphologic abnormalities of cardiac cell membranes. Potassium loss and sodium gain, like the lipid alteration, was more prominent in the subendocardium. Thus, chronic ethanol ingestion in this animal model is associated with abnormalities of ventricular function without evident malnutrition, analogous to the preclinical malfunction described in the human alcoholic.
D000437:Alcoholism / Q000378:metabolism / Q000503:physiopathology*; D000804:Angiotensin II; D000818:Animals; D001794:Blood Pressure; D002250:Carbon Radioisotopes; D002306:Cardiac Volume; D009202:Cardiomyopathies / Q000209:etiology; D002462:Cell Membrane / Q000378:metabolism; D004032:Diet; D004195:Disease Models, Animal; D004285:Dogs; D000431:Ethanol / Q000008:administration & dosage; D006321:Heart / Q000503:physiopathology*; D006352:Heart Ventricles; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009829:Oleic Acids / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism; D014815:Vitamins / Q000378:metabolism; D014882:Water-Electrolyte Balance
D002250:Carbon Radioisotopes; D009829:Oleic Acids; D010743:Phospholipids; D014280:Triglycerides; D014815:Vitamins; D000804:Angiotensin II; D000431:Ethanol